Market Closed -
Other stock markets
|
After market 02:58:53 pm | |||
6.33 EUR | +2.10% | 6.345 | +0.24% |
Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.90% | 144M | |
+21.96% | 47.9B | |
+46.56% | 41.42B | |
-2.38% | 40.7B | |
-6.20% | 28.92B | |
+10.86% | 25.55B | |
-21.30% | 19.27B | |
-1.79% | 12.15B | |
+30.56% | 12.14B | |
-0.54% | 11.99B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Ose Immunotherapeutics, GenDx to Co-develop Diagnostic Test Companion for Cancer Vaccine Trial